March 26, 2009 - Calypso Medical Technologies, Inc. said today that First Coast Service Options, the Medicare Administrative Contractor for Florida, Puerto Rico and the U.S. Virgin Islands, assigned region-wide payment amounts to the CPT code 0197T for intrafraction tracking to capture daily use of the Calypso 4D Localization System

In addition, the Calypso said that several national commercial payers and Medicare Administrative Contractors are paying claims for Calypso Medical’s implantable Beacon electromagnetic transponders. These transponders, smaller than a grain of rice, are placed in or around a tumor and tracked continuously during external beam radiation therapy.

Known as GPS for the Body, the Calypso 4D Localization System provides precise, continuous information on the location of the tumor during external beam radiation therapy. Any movement by the patient, including internal movement of the tumor, may cause the radiation to miss its intended target and hit adjacent healthy tissue. In contrast to other tumor targeting solutions, GPS for the Body technology provides continuous tumor position information, objectively and without ionizing radiation, thereby enabling optimization of the delivery of radiation to the tumor and minimization of misapplied radiation to normal tissue.

For more information: www.calypsomedical.com


Additional Content

News | Radiology Business

April 10, 2026 — The radiation therapy team at The Ohio State University Wexner Medical Center, The James Cancer ...

Time April 10, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | FDA

March 20, 2026 — Siemens Healthineers recently announced its Varian TrueBeam radiotherapy systems, which include ...

Time March 24, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
Subscribe Now